{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T12:04:10Z","timestamp":1765713850474},"reference-count":22,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2009,4,24]],"date-time":"2009-04-24T00:00:00Z","timestamp":1240531200000},"content-version":"vor","delay-in-days":8636,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Scandinavian Journal of Haematology"],"published-print":{"date-parts":[[1985,9]]},"abstract":"<jats:p>19 patients with MPD have been studied. As described in normals, an age\u2010related increase in \u03b2 thromboglobulin (\u03b2TG) release is observed. Such release, however, is greater in patients with myeloproliferative disorders (MPD). MPD seem therefore to cause platelet activation, allowing an earlier and more evident manifestation of physiologic ageing phenomena. PF 4 levels are near zero both in controls and patients, regardless of platelet number. This suggests that increased levels of PF 4 represent only a laboratory artifact, caused by platelet activation in vitro. Mean ability in producing thromboxane B<jats:sub>2<\/jats:sub> (TxB<jats:sub>2<\/jats:sub>) is increased, but is perfectly normal in patients with normal platelet count and decreased in 3 thrombocythaemic patients, who seem to present an increased thrombotic risk. TxB<jats:sub>2<\/jats:sub> is reduced almost to zero by the administration of aspirine plus dipyridamole; contrarily, all other parameters were unaffected, either by such drugs or by AD 6, a new coumarin derivative with antiplatelet properties.<\/jats:p>","DOI":"10.1111\/j.1600-0609.1985.tb01709.x","type":"journal-article","created":{"date-parts":[[2010,8,4]],"date-time":"2010-08-04T22:45:17Z","timestamp":1280961917000},"page":"299-304","source":"Crossref","is-referenced-by-count":8,"title":["PF 4 versus \u03b2TG as evidence for platelet activation in myeloproliferative disorders"],"prefix":"10.1111","volume":"35","author":[{"given":"G.","family":"Luzzatto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Fabris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Mazzucato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Girolami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,4,24]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V64.1.1.1"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1159\/000206503"},{"key":"e_1_2_1_4_2","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0308-2261(21)00376-3","article-title":"Thrombocytosis and thrombocythemia","volume":"12","author":"Murphy S.","year":"1983","journal-title":"Clin Haematol"},{"key":"e_1_2_1_5_2","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1055\/s-0038-1657031","article-title":"Platelet malonyldialdheyde and spontaneous aggregation during ischaemic attacks in patients with polycythemia vera","volume":"42","author":"Cortellazzo S.","year":"1979","journal-title":"Thromb Haemost"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1978.tb03646.x"},{"key":"e_1_2_1_7_2","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1055\/s-0038-1657135","article-title":"Biochemical and metabolic aspects of platelet disfunction in chronic myeloproliferative disorders","volume":"47","author":"Pareti FI","year":"1982","journal-title":"Thromb Haemost"},{"key":"e_1_2_1_8_2","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1182\/blood.V58.3.607.607","article-title":"Studies of human platelet alpha granule release in vivo","volume":"58","author":"Files JC","year":"1981","journal-title":"Blood"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198202183060701"},{"key":"e_1_2_1_10_2","unstructured":"ProsdocimiM. ZattaA. FabrisF. LuzzattoG. DejanaE.Prevention of platelet aggregation and release reaction by AD 6 a new coumarinic derivative. (Abstract). Iuphar 9th international congress of pharmacology London 1984."},{"key":"e_1_2_1_11_2","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1055\/s-0038-1653415","article-title":"The effect of anticoagulant mixtures on \u03b2TG and PF 4 levels","volume":"46","author":"Randi ML","year":"1981","journal-title":"Thromb Haemost"},{"key":"e_1_2_1_12_2","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1182\/blood.V57.2.199.199","article-title":"Plasma levels of \u03b2\u2010thromboglobulin and platelet factor 4 as indices of platelet activation in vivo","volume":"57","author":"Kaplan KL","year":"1981","journal-title":"Blood"},{"key":"e_1_2_1_13_2","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1055\/s-0038-1650172","article-title":"Platelet activation in myeloproliferative disorders","volume":"45","author":"Cortellazzo S.","year":"1981","journal-title":"Thromb Haemost"},{"key":"e_1_2_1_14_2","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1055\/s-0038-1657212","article-title":"In vivo platelet release in myeloproliferative disorders","volume":"48","author":"Ireland H.","year":"1982","journal-title":"Thromb Haemost"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1979.tb05855.x"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/0049-3848(80)90067-5"},{"key":"e_1_2_1_17_2","first-page":"369","article-title":"Platelet factor 4 in patients with coronory artery disease","volume":"97","author":"White GC","year":"1981","journal-title":"J Lab Clin Med"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1159\/000206365"},{"key":"e_1_2_1_19_2","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1055\/s-0038-1661297","article-title":"The value of \u03b2TG\/PF 4 ratio in patients with high platelet count","volume":"53","author":"Fabris F.","year":"1985","journal-title":"Thromb Haemost"},{"key":"e_1_2_1_20_2","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1055\/s-0038-1661162","article-title":"Clearance and in vivo release by heparin of human platelet factor 4 (PF 4) in the rabbit","volume":"52","author":"Prosdocimi M.","year":"1984","journal-title":"Thromb Haemost"},{"key":"e_1_2_1_21_2","first-page":"119","article-title":"Platelet thromboxane synthesis and release reactions in myeloproliferative disorders","volume":"11","author":"Smith IL","year":"1982","journal-title":"Haemostas"},{"key":"e_1_2_1_22_2","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1182\/blood.V54.6.1258.1258","article-title":"Altered arachidonate metabolism in patients with myeloproliferative disorders","volume":"54","author":"Okuma M.","year":"1979","journal-title":"Blood"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1982.tb01900.x"}],"container-title":["Scandinavian Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0609.1985.tb01709.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0609.1985.tb01709.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,21]],"date-time":"2023-10-21T05:14:17Z","timestamp":1697865257000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0609.1985.tb01709.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1985,9]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1985,9]]}},"alternative-id":["10.1111\/j.1600-0609.1985.tb01709.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0609.1985.tb01709.x","archive":["Portico"],"relation":{},"ISSN":["0036-553X"],"issn-type":[{"value":"0036-553X","type":"print"}],"subject":[],"published":{"date-parts":[[1985,9]]}}}